Insider · CIK 0001245624
HEALY JAMES
Reports to the SEC for 40 companies · EMERYVILLE, CA
Transactions
50
Companies
40
Filings
6
CIK
0001245624
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-10 | RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-10 | BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-05-04 | SPTXSeaport Therapeutics, Inc. · Series B Preferred StockC Conversion | — |
| 2026-05-04 | SPTXSeaport Therapeutics, Inc. · Series A-2 Preferred StockC Conversion | — |
| 2026-05-04 | SPTXSeaport Therapeutics, Inc.C Conversion | — |
| 2026-05-04 | SPTXSeaport Therapeutics, Inc.C Conversion | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.U Disposition from Tender | −$272K |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.D Disposition to Issuer | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.U Disposition from Tender | −$18.9M |
| 2025-09-16 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-06-30 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award | — |
| 2025-06-30 | Y-mAbs Therapeutics, Inc.A Award | — |
| 2025-06-17 | RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-05 | BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-04-25 | NTRANatera, Inc.A Award | — |
| 2025-01-31 | NTRANatera, Inc.A Award | — |
| 2024-10-25 | NTRANatera, Inc.A Award | — |
| 2024-09-27 | BIOABioAge Labs, Inc.P Purchase | +$393K |
| 2024-09-27 | BIOABioAge Labs, Inc.P Purchase | +$200K |
| 2024-09-27 | BIOABioAge Labs, Inc.P Purchase | +$330K |
| 2024-09-27 | BIOABioAge Labs, Inc.P Purchase | +$10.6M |
| 2024-09-27 | BIOABioAge Labs, Inc.P Purchase | +$477K |
| 2024-09-27 | BIOABioAge Labs, Inc.C Conversion | — |
| 2024-09-27 | BIOABioAge Labs, Inc. · Series D Preferred StockC Conversion | — |
| 2024-09-25 | BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-07-26 | NTRANatera, Inc.A Award | — |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$81.6K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$86.3K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$114K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$83.8K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$122K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$68.4K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$87.7K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$117K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$88.5K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$92.7K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$71.6K |
| 2024-07-01 | RAPPRapport Therapeutics, Inc.P Purchase | +$66.7K |
| 2024-06-28 | NTRANatera, Inc.A Award | — |
| 2024-06-12 | BOLTBolt Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-11 | Y-mAbs Therapeutics, Inc.A Award | — |
| 2024-06-11 | Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award | — |
| 2024-06-10 | RAPPRapport Therapeutics, Inc.P Purchase | +$304K |
Recent filings
- 4HEALY JAMES0001245624-26-000002SEC(opens sec.gov)
- 4HEALY JAMES0001193125-26-266095SEC(opens sec.gov)
- 4HEALY JAMES0001193125-26-204494SEC(opens sec.gov)
- 4HEALY JAMES0001245624-25-000004SEC(opens sec.gov)
- 4HEALY JAMES0001415889-25-019047SEC(opens sec.gov)
- 4HEALY JAMES0000950170-25-087901SEC(opens sec.gov)
Companies
- Aclaris Therapeutics, Inc.10% OwnerACRS
- AERIE PHARMACEUTICALS INC10% Owner
- Akouos, Inc.10% Owner
- ALIMERA SCIENCES INC10% Owner
- AMARIN CORP PLC\UKDirectorAMRN
- Anthera Pharmaceuticals IncDirector
- Aravive, Inc.10% Owner
- ArriVent BioPharma, Inc.DirectorAVBP
- aTYR PHARMA INC10% OwnerATYR
- BioAge Labs, Inc.DirectorBIOA
- Bolt Biotherapeutics, Inc.DirectorBOLT
- Checkmate Pharmaceuticals, Inc.10% Owner
- CinCor Pharma, Inc.Director, 10% Owner
- Coherus Oncology, Inc.DirectorCHRS
- COTHERIX INCDirector, 10% Owner
- Durata Therapeutics, Inc.Director, 10% Owner
- Entasis Therapeutics Holdings Inc.10% Owner
- Galera Therapeutics, Inc.10% OwnerGRTX
- HUMANIGEN, INCDirector
- HYPERION THERAPEUTICS INCDirector, 10% Owner
- Inozyme Pharma, Inc.10% Owner
- INTERMUNE INCDirector
- Iterum Therapeutics plc10% OwnerITRM
- Jade Biosciences, Inc.10% OwnerJBIO
- Karuna Therapeutics, Inc.Director
- MARINUS PHARMACEUTICALS, INC.10% Owner
- Molecular Templates, Inc.10% Owner
- Natera, Inc.DirectorNTRA
- NextCure, Inc.10% OwnerNXTC
- Ocera Therapeutics, Inc.10% Owner
- Ocugen, Inc.10% OwnerOCGN
- PDS Biotechnology CorpDirectorPDSB
- Principia Biopharma Inc.10% Owner
- Rapport Therapeutics, Inc.DirectorRAPP
- Seaport Therapeutics, Inc.DirectorSPTX
- Spark Therapeutics, Inc.10% Owner
- SYNLOGIC, INC.10% OwnerSYBX
- Trius Therapeutics Inc10% Owner
- Vera Therapeutics, Inc.10% OwnerVERA
- Y-mAbs Therapeutics, Inc.Director
Address
C/O BIOAGE LABS, INC. 5885 HOLLIS STREET, SUITE 370
EMERYVILLE, CA, 94608